Skip to Main Content (Press Enter)

Logo UNINSUBRIA
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze

UNI-FIND
Logo UNINSUBRIA

|

UNI-FIND

uninsubria.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  1. Pubblicazioni

BLOOD

Rivista
Codice:
E023052
ISSN:
0006-4971
  • Dati Generali

Dati Generali

Pubblicazioni (147)

  • ascendente
  • decrescente
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis
Articolo
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
Articolo
A prognostic model to predict survival in 867 WHO-defined essential thrombocythemia at diagnosis: a study by the IWG-MRT.
Articolo
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms
Articolo
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment
Contributo in Atti di convegno
Adherence to the Mediterranean diet is associated with lower platelet and leukocyte counts: results from the Moli-sani study
Articolo
Age-sex-specific ranges of platelet count and all-cause mortality: Prospective findings from the MOLI-SANI study
Articolo
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
Articolo
Array-CGH Identifies Both Common and Subtype-Specific Genomic Aberrations in Marginal Zone Lymphomas. Abstract n. 622,
Abstract
Array-CGH Identifies Regions, Including the FOXP1 Locus, Associated with Different Clinical Outcome in Diffuse Large B-Cell Lymphomas (DLBCL) Treated with R-CHOP.
Abstract
B-cell Acute Lymphoblastic Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Lenalidomide
Articolo
BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia
Abstract
CD73-generated extracellular adenosine creates microenvironmental conditions favoring growth and survival of chronic lymphocytic leukemia cells
Contributo in Atti di convegno
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
Articolo
CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective pharmacological profile competitive with bortezomib
Articolo
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Articolo
Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia
Articolo
Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study)
Abstract
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo
Articolo
Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification
Contributo in Atti di convegno
Chronic Myeloid Leukemia: Molecular Monitoring of Residual Disease by Genomic DNA Compared to Conventional mRNA Analysis in Follow-Ups up to 8 Years
Abstract
Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06
Abstract
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years
Articolo
Clinicopathological Differences Between Asian and Western Patients with De Novo Diffuse Large B Cell Lymphoma Treated with R-CHOP
Abstract
Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells
Contributo in Atti di convegno
Development and validation of an International Prognostic Score of thrombosis in WHO-Essential Thrombocythemia (IPSET-thrombosis).
Articolo
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis
Abstract
Disease anticipation in familial myeloproliferative neoplasms.
Articolo
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early /prefibrotic primary myelofibrosis.
Articolo
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients
Articolo
Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis.
Articolo
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
Articolo
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine
Abstract
Efficacy and Safety of Bendamustine and Rituximab As First Salvage Treatment in Chronic Lymphocytic Leukemia: Results of the Gimema-Eric LLC1315 Study
Abstract
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia
Abstract
Expression of the Tigit/CD226/CD155 Receptors/Ligand System in Chronic Lymphocytic Leukemia
Abstract
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism
Contributo in Atti di convegno
Extracellular matrix structure and nano-mechanics determine megakaryocyte function.
Articolo
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
Articolo
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System
Abstract
Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia
Abstract
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)
Abstract
Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study
Contributo in Atti di convegno
Genetic and phenotypic attributes of splenic marginal zone lymphoma
Articolo
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
Articolo
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.
Articolo
Germline RBBP6 mutations in familial myeloproliferative neoplasms
Articolo
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target
Contributo in Atti di convegno
How I treat polycythemia vera
Articolo
How I treat splanchnic vein thrombosis
Articolo
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.
Articolo
Human HTLV-II virus directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope associated HLA class II molecules reverse this effect.
Articolo
Human T-cell leukemia virus type II (HTLV-II) directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope-associated HLA class II molecules reverse this effect
Articolo
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Abstract
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals
Abstract
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia
Abstract
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia
Abstract
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)
Abstract
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06
Abstract
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy
Articolo
Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis
Articolo
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study
Articolo
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts
Articolo
In Vitro Activity of SYK and BCR-ABL Inhibitors in Aggressive Lymphomas.
Abstract
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism
Articolo
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation
Articolo
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study
Articolo
Infusion of autologous Epstein-Barr virus (EBV) - specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
Articolo
Inhibition of the B Cell Associated Tyrosine Kinase SYK as a Potential Therapeutic Target in Aggressive Lymphomas. 106: 1469.
Abstract
Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome.
Articolo
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients
Abstract
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.
Articolo
LDH Levels Predict Progression-Free Survival in Treatment-NaIVe Patients with Trisomy 12 Chronic Lymphocytic Leukemia
Abstract
Long term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls.
Articolo
Longitudinal Assessment of CLL Patients Under Ibrutinib Treatment Reveals Maintained Capacity to Respond to Microenvironmental Stimuli through the Toll-like Receptors
Contributo in Atti di convegno
Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.
Articolo
Low efficacy of thalidomide in improving response after induction in myeloma patients candidate to high-dose therapy
Abstract
MYELOMA CELLS DRIVE THE MATURATION OF DENDRITIC CELLS VERSUS A TH2-PROMOTING PHENOTYPE WHICH IMPAIRS T-CELL ACTIVATION
Contributo in Atti di convegno
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients
Articolo
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Articolo
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
Articolo
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03cooperative trial
Articolo
Molecular prediction of durable remission after first-line fludarabinecyclophosphamide-rituximab in chronic lymphocytic leukemia
Articolo
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22
Abstract
Myeloma cells drive the maturation of dendritic cells versus a Th2-promoting phenotype which impairs T-cell activation
Contributo in Atti di convegno
NODAL MARGINAL ZONE B-CELL LYMPHOMAS MAY ARISE FROM DIFFERENT SUBSETS OF MARGINAL ZONE B LYMPHOCYTES
Articolo
NOTCH1 Stabilization By PEST Mutations Enhances IgM-Mediated Activity in Chronic Lymphocytic Leukemia
Abstract
Natural history of cerebral vein thrombosis: a systematic review
Articolo
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Articolo
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
Articolo
Organization of alpha-globin genes in Hb Hasharon(alpha 47 asp replaced by his) carriers
Articolo
Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib within a Named Patient Program (NPP) in Italy. a Real-Life Retrospective Study
Abstract
Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/TP53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study
Contributo in Atti di convegno
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
Articolo
PDGFRB disease: right diagnosis to prolong survival
Articolo
Percutaneous radiofrequency tissue ablation for the treatment of post-transplant lymphoproliferative disorders (PTLD): Case report.
Articolo
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells
Contributo in Atti di convegno
Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs
Abstract
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs
Articolo
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis
Articolo
Primary testicular non-Hodgkin lymphomas. A clinicopathologic study of nine cases
Abstract
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom
Abstract
Rapid Molecular Detection of Pathogens in 516 Consecutive Haematological Patients with Febrile Neutropenia
Abstract
Recognition of human T Leukaemia virus (HTLV-I) envelope by human CD4+ T cell lines from HTLV-I seronegative individuals: specificity and clonal heterogeneity.
Articolo
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia
Articolo
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting
Abstract
Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions
Contributo in Atti di convegno
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders
Articolo
Resistance of naturally occurring regulatory T cells toward oxidative stress: possible link with intracellular catecholamine content and implications for cancer therapy
Articolo
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.
Articolo
Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report
Articolo
Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project
Articolo
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.
Articolo
Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer
Articolo
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results
Articolo
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy
Contributo in Atti di convegno
Sardinian G gamma-HPFH: aT----C substitution in a conserved "octamer" sequence in the G gamma-globinpromoter.
Articolo
Scoring System to Predict the Risk of Atrial Fibrillation in Chronic Lymphocytic Leukemia and Its Validation in a Cohort of Ibrutinib-Treated Patients
Abstract
Screening transplant donors for HTLV-1 and -2
Articolo
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells, Also Overcoming Intrinsic and Stromal Cells-Mediated Fludarabine Resistance
Contributo in Atti di convegno
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis
Abstract
Small clots with large impact
Articolo
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
Articolo
Stem cell transplant in MF: It’s time to personalize
Articolo
Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP.
Abstract
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status
Abstract
The Hypoxia-Inducible Factor-1 alpha Is Constitutively Upregulated in TP53 Disrupted CLL Cells: A Potential Target to Overcome Fludarabine Resistance
Contributo in Atti di convegno
The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP 116: 4126.
Abstract
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2
Articolo
The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells
Abstract
The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells
Abstract
The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL)
Abstract
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.
Articolo
The PD-1/PD-L1 Axis Contributes to T Cell Dysfunction in Chronic Lymphocytic Leukemia
Abstract
The homozygous state of G toA--117A gamma hereditary persistence of fetal hemoglobin.
Articolo
The role of jak2 inhibitors in mpns 7 years after approval
Articolo
The role of thrombolytic therapy in pulmonary embolism
Articolo
The small proteoglycan decorin supports adhesion and activation of human platelets
Articolo
Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis
Articolo
Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis
Articolo
Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events.
Articolo
Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.
Articolo
To the editor: In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology
Articolo
Tyrosin-Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
Abstract
Unmutated IGHV1-69/D3-16/J3 Stereotyped HCDR3 Rearrangements (Subset 6) Are Associated with Indolent Disease Course and Have Outcome Independent of Mutational Status In Early Stage CLL (Rai 0)
Abstract
Validation of cytogenetic-based risk stratification in primary myelofibrosis.
Articolo
Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+NaiVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study
Abstract
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Accessibilità
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0